Fake rallies or not, price action has been up . Those in at 7 are happy or cashing out , those in at 30 feel like #$#%. The stock market allways will be a best guestimate, and fake rallies will make some money and sucker in others. It is all about timing. Watsa is still down big on his bbry fully diluted holding. P.S. if there are fake rallies are there fake drops? If we all had crystal balls-we would walk funny.
Wow - you think the government cares how much the taxpayers lose. The CP has to be thoroughly vetted given it is the first in the new biosimilar gene game. Thus it will be months before any approval which will go to Momenta for an at risk launch for the exclusivity period.
No way- with the new CP just filed it will be months for all parties to put their input together for the FDA to say it gave everyone reasonable consideration.
If instead of creating a new company, MLP wood processing. They kept the current corporate structure and simply paid a dividend? Could we see 10 dollars?
More to come?
maybe touch at 2;25 in a month
If the company goes private means a specific price paid for all shares. options will adjust.
Not so fast.
The judge rejected Momenta/Sandoz and Mylan/Natco’s claims that the COPAXONE® patents are invalid and unenforceable and found that the purported generic versions of COPAXONE® for which Momenta/Sandoz and Mylan/Natco seek Food and Drug Administration (FDA) approval infringe those patents. This ruling should prevent the FDA from approving, and the defendants from selling their purported generic versions of COPAXONE® in the U.S. until the Orange Book patents expire on May 24, 2014. As a result of this ruling, Teva also believes that the defendants will be enjoined from selling their products until the process patent expires on September 1, 2015. Furthermore, any purported generic version of COPAXONE® would need to obtain FDA approval prior to being made available to the public. At this point, it is unclear what the requirements would be for approval of a purported generic synthetic peptide.
Got the same impression. Too much risk due to no FDA approval. The month of June has come and almost gone.
Given past credibility issues of management, and they do not admit to their faults, they have never met their projections. Expect this pie in the sky to fall flat.
More interested on how they plan to spend Blackstones millions to increase top and bottom line. Timelines and particulars will help this get past 3.00$. Seams like everyone has written off RNF as high gas prices and low product prices and the need to replenish capital has people believing in no qtr distribution. We will see.
Approval comes when the FDA is satisfied with efficacy , similarity and a number of other points. This could of came months ago if it met their guidelines. I believe the FDA does not care about patent expiration , they are not the patent office or a legal entity that should be concerned about such matters. That is what the courts are for. With that said I don't expect approval any time soon. With the major price drop over last couple months , a lot of people do not expect it either. But some times the world surprises. But I think that the May date will come and go with nothing. Momenta will still say they are in communication with the FDA in their next CC same as they have last 5 quarters or so..
Still believe it is apple to apple . Both produce nitrogen fertilizer products anhydrous ammonia , UAN and a little DEF(diesel exhaust fluid) UAn uses pet coke(only one in US) RNF uses natural gas to produce same. Last year gas cost 4/ mcfu compared with around 5 this qtr. Now RNF does receive a premium do to their geographical location, but I do not think that will cover much of the increase in input costs. They also mentioned that they might want to retain some dollars from a capital structure do to the costs last quarter. While they can pull funds from all upcoming qtrs to make up for their shortfall , won't know till they announce how bad any one quarter will be hit.
UAN -reported and slashed their distribution to 60% of last years. If that reflective of pricing pressure(lower selling prices) and their input prices did not change much. The increased input prices for RNF are up a lot and selling prices down expect distribution in range of 15-25 cents only. 2nd quarter should be better. 2 dollars for the year, looks tough. JMHO
"We are off to a solid start to the year and are pleased to reaffirm our 2014 guidance. At the same time, it is important to note that we have launched a tremendous number of new retailers and new products over the past six months, and it will take more time to develop certainty as to how customer acquisition rates, active card numbers, and behavioral trends related to these new products and new retailers will play out through the remainder of the year. Therefore, while we are quite pleased with Q1 results, we want to caution analysts and investors not to get ahead of our guidance as we wait to see trends on key metrics more fully develop in successive quarters,” said Grace Wang, Green Dot Chief Financial Officer.